Changzhou-based medical device maker founded in 2013, developing implantable vagus nerve and spinal cord stimulators.
Established in 2013 and based in Changzhou, China, Rishena researches and develops active implantable medical devices. Its main products include implantable vagus nerve stimulators, implantable rechargeable spinal cord stimulators and concha vagus nerve stimulators (t-VNS), used for conditions such as epilepsy and Parkinson's disease. In 2021 the company launched a non-implantable concha vagus nerve stimulator (tVNS501) and SEL-4XX series intracranial brain electrodes. In May 2023 it raised an undisclosed strategic investment from new investor Proxima Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in